Desq Long
Sign in
SEC FORM 4
$102,500.00

Vivos Therapeutics, Inc. (VVOS)

Acquisition (code A) of 250,000 shares at $0.41 per share.

Reporting Person Amman Bradford K. · Officer Title Principal Accounting Officer · Transaction Code A

Traded Jul 31, 2026 · Disclosed Aug 26, 2026FILED +26 DAYS

Source: SEC Form 4 · 0001493152-26-040238 · filed 2026-08-26 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Vivos Therapeutics, Inc. (VVOS)." Disclosed 2026-08-26. https://desqlong.com/cards/0001493152-26-040238-1 (retrieved 2026-09-26).